Search Results
Oct 21, 2025, 08:18 ET aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman
market opportunity. "We're scrutinizing whether aTyr's previous representations about the drug's efficacy were materially misleading to investors," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation. If you invested in aTyr and have substantial losses, or
More news about: Hagens Berman Sobol Shapiro LLP
Oct 21, 2025, 08:17 ET MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
have intentionally misled investors about the SLK's purported advantages over BIMZELX while claiming that SLK could become a 'gold standard,'" said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in MoonLake and have substantial losses, or have
More news about: Hagens Berman Sobol Shapiro LLP
Oct 21, 2025, 08:13 ET LFMD 6-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
investigating these claims. "We're investigating whether LifeMD knew of but failed to disclose key operational problems," said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in LifeMD and have substantial losses, or have
More news about: Hagens Berman Sobol Shapiro LLP
Oct 21, 2025, 05:11 ET NUTX DEADLINE ALERT: Nutex Health (NUTX) Investors Alerted to Today's Lead Plaintiff Deadline in Securities Class Action
Hagens Berman Launches Probe Law firm Hagens Berman Sobol Shapiro LLP is investigating the claims. Reed Kathrein, a partner at the firm, stated: "We're examining whether Nutex's business model was predicated on questionable arbitration tactics and whether
More news about: Hagens Berman Sobol Shapiro LLP
Oct 20, 2025, 08:00 ET RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor
systematic review and meta-analysis. Clin Rheumatol. 2022 Dec;41(12):3615-3627. Furst DE, Pangan AL, Harrold LR, Chang H, Reed G, Kremer JM, Greenberg JD. Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the
More news about: AbbVie
Oct 17, 2025, 09:27 ET aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman
market opportunity. "We're scrutinizing whether aTyr's previous representations about the drug's efficacy were materially misleading to investors," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation. If you invested in aTyr and have substantial losses, or
More news about: Hagens Berman Sobol Shapiro LLP
Oct 17, 2025, 09:25 ET KBR, Inc. (KBR) Faces Securities Class Action Amid TRANSCOM Contract Termination-Hagens Berman
"We're focused on whether KBR may have intentionally misled investors about the true status of the relationship with TRANSCOM and the contract," said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in KBR and have substantial losses, or have knowledge
More news about: Hagens Berman Sobol Shapiro LLP
Oct 17, 2025, 09:21 ET LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman
investigating these claims. "We're investigating whether LifeMD knew of but failed to disclose key operational problems," said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in LifeMD and have substantial losses, or have
More news about: Hagens Berman Sobol Shapiro LLP
Oct 17, 2025, 09:19 ET Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
Hagens Berman Launches Probe Law firm Hagens Berman Sobol Shapiro LLP is investigating the claims. Reed Kathrein, a partner at the firm, stated: "We're examining whether Nutex's business model was predicated on questionable arbitration tactics and whether
More news about: Hagens Berman Sobol Shapiro LLP
Oct 17, 2025, 09:17 ET AI 4-DAY DEADLINE ALERT: Investors Allege Misleading Statements in C3.ai (AI) Class Action Lawsuit-- Hagens Berman
their failure to fully disclose how CEO Thomas M. Siebel's health was affecting the company's ability to close deals and meet financial targets," said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in C3.ai and have substantial losses, or have
More news about: Hagens Berman Sobol Shapiro LLP
Oct 17, 2025, 08:30 ET MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
have intentionally misled investors about the SLK's purported advantages over BIMZELX while claiming that SLK could become a 'gold standard,'" said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in MoonLake and have substantial losses, or have
More news about: Hagens Berman Sobol Shapiro LLP
Oct 17, 2025, 04:35 ET Shanghai-London Screen Industry Forum Returns for Third Edition, Strengthening Sino-British Creative Ties and Showcasing Global Storytelling
Tell Global Stories across East and West, explored the nuances of creating content that resonates internationally. Participants included Rosemary Reed of POW TV Studios, Jiella Esmat of 8 Lions, and Cedric Behrel of Trinity CineAsia. By continuing to unite influential voices
More news about: Phoenix TV
Oct 17, 2025, 04:00 ET Shanghai-London Screen Industry Forum Returns for Third Edition, Strengthening Sino-British Creative Ties and Showcasing Global Storytelling
Tell Global Stories across East and West, explored the nuances of creating content that resonates internationally. Participants included Rosemary Reed of POW TV Studios, Jiella Esmat of 8 Lions, and Cedric Behrel of Trinity CineAsia. By continuing to unite influential voices
More news about: Phoenix TV
Oct 16, 2025, 15:01 ET MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
have intentionally misled investors about the SLK's purported advantages over BIMZELX while claiming that SLK could become a 'gold standard,'" said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in MoonLake and have substantial losses, or have
More news about: Hagens Berman Sobol Shapiro LLP
Oct 15, 2025, 10:50 ET Small Gas Engines Market Surges to USD 9.1 Billion by 2033, Propelled by 4.5% CAGR - Verified Market Reports®
2-Stroke Gas Engines 4-Stroke Gas Engines Reed Valve Gas Engines Ported Gas Engines By
More news about: Verified Market Reports
Oct 15, 2025, 09:30 ET Healthcare Litigator and Former DOJ Civil Fraud Section Leader Jeff Gleason Joins Crowell & Moring
that has experienced significant growth in recent months. In August, the firm added a highly regarded managed care team of more than 50 attorneys from Reed Smith, establishing one of the largest health care practices in the country and significantly expanding the firm's ability to serve clients across the
More news about: Crowell & Moring LLP
Oct 15, 2025, 09:15 ET Truck Parking Club Surpasses 3,000 Locations Nationwide, Redefining Fleet Parking Operations with On-Demand Flexibility
. Media ContactReed LoustalotCMO - Truck Parking [email protected]
More news about: TruckParkingClub.com
Oct 15, 2025, 09:00 ET NBA Commissioner Adam Silver to Receive 2026 Edison Achievement Award
www.edisonawards.com. Media Contacts: Edison AwardsRachel ReedDirector of [email protected]
More news about: Edison Awards
Oct 15, 2025, 07:00 ET Generosity Xchange 2025 Brings Nonprofit Leaders Together to Reimagine the Future of Giving
This year's conference features a keynote conversation between Diane Yentel, president and CEO of the National Council of Nonprofits; Keith Reed, CEO of Neon One; Anne Gingerich, executive director of the Pennsylvania Association of Nonprofit Organizations (PANO); and Rachel D'Souza, founder of
More news about: Neon One
Oct 14, 2025, 22:16 ET Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
Hagens Berman Launches Probe Law firm Hagens Berman Sobol Shapiro LLP is investigating the claims. Reed Kathrein, a partner at the firm, stated: "We're examining whether Nutex's business model was predicated on questionable arbitration tactics and whether
More news about: Hagens Berman Sobol Shapiro LLP
Oct 14, 2025, 15:34 ET CarMax, Inc. (KMX) Faces Investor Scrutiny After Unexpected $142 Million Loss Provision Sends Shares Tumbling -- Hagens Berman
20%. "We're focused on investors' losses and whether CarMax may have misled investors about the quality of the CAF portfolio," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation. If you invested in CarMax and have substantial losses,
More news about: Hagens Berman Sobol Shapiro LLP
Oct 14, 2025, 12:03 ET MoonLake Immunotherapeutics (MLTX) Faces Investor Scrutiny After Reporting Disappointing Phase 3 Trial Data For Lead Drug Candidate -- Hagens Berman
investors about the VELA-2 design and planning for potential intercurrent events while claiming that sonelokimab could become a 'gold standard'," said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in MoonLake and have substantial losses, or have
More news about: Hagens Berman Sobol Shapiro LLP
Oct 14, 2025, 10:26 ET LFMD 13-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
investigating these claims. "We're investigating whether LifeMD knew of but failed to disclose key operational problems," said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in LifeMD and have substantial losses, or have
More news about: Hagens Berman Sobol Shapiro LLP
Oct 14, 2025, 10:23 ET Snap Inc. (SNAP) Faces Class Action Over Ad Platform, Investors Allege Misleading Statements -- Hagens Berman
transparent about the ad platform changes that ultimately caused a sharp deceleration in revenue growth and a significant drop in share price," said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in Snap and have substantial losses, or have knowledge
More news about: Hagens Berman Sobol Shapiro LLP
Oct 14, 2025, 10:17 ET KBR, Inc. (KBR) Faces Securities Class Action Amid TRANSCOM Contract Termination-Hagens Berman
"We're focused on whether KBR may have intentionally misled investors about the true status of the relationship with TRANSCOM and the contract," said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in KBR and have substantial losses, or have knowledge
More news about: Hagens Berman Sobol Shapiro LLP